title: FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma.
abstract: It has been reported, as a result of Western blot analyses, that FKBP51 is expressed in various tissues, but that it is not expressed in the pancreas, lung, colon, stomach, or spleen. In this paper, we show, using Western blot analyses, reverse transcriptase polymerase chain reaction, and immunohistochemical analyses of samples from colon cancer patients, that both normal epithelial cells and adenocarcinoma in the human colon express FKBP51, and that there are no significant differences in the expressions of FKBP51 between them. We also show that FKBP51 suppresses the proliferation of colorectal adenocarcinoma, possibly due to the suppression of functions of the glucocorticoid receptors.
authors.affiliation: First Department of Pathology, Kansai Medical University, Moriguchi City, Osaka, Japan.
authors.forename: Hiromi
authors.initials: H
authors.lastname: Mukaide
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Adachi
authors.forename: Shigeru
authors.initials: S
authors.lastname: Taketani
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Iwasaki
authors.forename: Naoko
authors.initials: N
authors.lastname: Koike-Kiriyama
authors.forename: Akio
authors.initials: A
authors.lastname: Shigematsu
authors.forename: Ming
authors.initials: M
authors.lastname: Shi
authors.forename: Seiji
authors.initials: S
authors.lastname: Yanai
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Yoshioka
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Kamiyama
authors.forename: Susumu
authors.initials: S
authors.lastname: Ikehara
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D003106:Colon / Q000378:metabolism*; D015179:Colorectal Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D004847:Epithelial Cells / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D008775:Methylprednisolone / Q000494:pharmacology; D015735:Mifepristone / Q000494:pharmacology; D009363:Neoplasm Proteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D012333:RNA, Messenger / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis; D034741:RNA, Small Interfering / Q000494:pharmacology; D011965:Receptors, Glucocorticoid / Q000187:drug effects / Q000502:physiology; D022021:Tacrolimus Binding Proteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D000099159:Tacrolimus Binding Protein 5
chemical_list: D008775:Methylprednisolone; D015735:Mifepristone; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D034741:RNA, Small Interfering; D011965:Receptors, Glucocorticoid; D022021:Tacrolimus Binding Proteins; D000099159:Tacrolimus Binding Protein 5